Coronary bypass surgery: protective effects of insulin or of prevention of hyperglycemia, or both?
暂无分享,去创建一个
[1] R. Hetzer,et al. Glucose-insulin-potassium therapy in adult patients undergoing cardiac surgery: a meta-analysis. , 2011, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[2] A. Marette,et al. Cardioprotective effects of glucose and insulin administration while maintaining normoglycemia (GIN therapy) in patients undergoing coronary artery bypass grafting. , 2011, The Journal of clinical endocrinology and metabolism.
[3] Jan Gunst,et al. Insufficient activation of autophagy allows cellular damage to accumulate in critically ill patients. , 2011, The Journal of clinical endocrinology and metabolism.
[4] N. Freemantle,et al. Glucose-Insulin-Potassium Reduces the Incidence of Low Cardiac Output Episodes After Aortic Valve Replacement for Aortic Stenosis in Patients With Left Ventricular Hypertrophy: Results From the Hypertrophy, Insulin, Glucose, and Electrolytes (HINGE) Trial , 2011, Circulation.
[5] Eileen White,et al. Autophagy and Metabolism , 2010, Science.
[6] Bart Meyns,et al. Tight glycemic control protects the myocardium and reduces inflammation in neonatal heart surgery. , 2010, The Annals of thoracic surgery.
[7] Lei Zhang,et al. High-dose glucose–insulin–potassium has hemodynamic benefits and can improve cardiac remodeling in acute myocardial infarction treated with primary percutaneous coronary intervention: From a randomized controlled study , 2010, Journal of cardiovascular disease research.
[8] A. Furnary. Clinical benefits of tight glycaemic control: focus on the perioperative setting. , 2009, Best practice & research. Clinical anaesthesiology.
[9] G. Van den Berghe,et al. Hyperglycemic kidney damage in an animal model of prolonged critical illness. , 2009, Kidney international.
[10] G. Meyfroidt,et al. Intensive insulin therapy in paediatric intensive care: a prospective randomized controlled study , 2009 .
[11] G. Van den Berghe,et al. Tissue-specific glucose toxicity induces mitochondrial damage in a burn injury model of critical illness , 2009, Critical care medicine.
[12] L. Foubert,et al. Tight perioperative glucose control is associated with a reduction in renal impairment and renal failure in non-diabetic cardiac surgical patients , 2008, Critical care.
[13] K. Lachapelle,et al. High-dose insulin therapy attenuates systemic inflammatory response in coronary artery bypass grafting patients. , 2008, The Annals of thoracic surgery.
[14] B. Ellger,et al. Modulation of regional nitric oxide metabolism: Blood glucose control or insulin? , 2008, Intensive Care Medicine.
[15] K. Reinhart,et al. Intensive insulin therapy in the ICU: benefit versus harm? , 2007, Intensive Care Medicine.
[16] Miet Schetz,et al. Strict blood glucose control with insulin during intensive care after cardiac surgery: impact on 4-years survival, dependency on medical care, and quality-of-life. , 2006, European heart journal.
[17] G. Van den Berghe,et al. Survival benefits of intensive insulin therapy in critical illness: impact of maintaining normoglycemia versus glycemia-independent actions of insulin. , 2006, Diabetes.
[18] J Herlitz,et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. , 2005, European heart journal.
[19] Jun Zhu,et al. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. , 2005, JAMA.
[20] Greet Van den Berghe,et al. How does blood glucose control with insulin save lives in intensive care , 2004 .
[21] P. Pagel,et al. Cardioprotection by glucose-insulin-potassium: dependence on KATP channel opening and blood glucose concentration before ischemia. , 2004, American journal of physiology. Heart and circulatory physiology.
[22] D. Yellon,et al. Insulin therapy as an adjunct to reperfusion after acute coronary ischemia: a proposed direct myocardial cell survival effect independent of metabolic modulation. , 2003, Journal of the American College of Cardiology.
[23] Miet Schetz,et al. Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control* , 2003, Critical care medicine.
[24] R. Marfella,et al. Acute hyperglycemia induces nitrotyrosine formation and apoptosis in perfused heart from rat. , 2002, Diabetes.
[25] F. Gao,et al. Ischemia-Reperfusion : The Roles of PI 3-Kinase , Akt , and Endothelial Nitric Oxide Nitric Oxide Mediates the Antiapoptotic Effect of Insulin in Myocardial , 2002 .
[26] G. V. Berghe,et al. Intensive insulin therapy in critically ill patients. , 2001, The New England journal of medicine.
[27] D. Yellon,et al. Myocardial Protection by Insulin at Reperfusion Requires Early Administration and Is Mediated via Akt and p70s6 Kinase Cell-Survival Signaling , 2001, Circulation research.
[28] P. Pagel,et al. Diabetes and hyperglycemia impair activation of mitochondrial K(ATP) channels. , 2001, American journal of physiology. Heart and circulatory physiology.
[29] D. Latchman,et al. Insulin administered at reoxygenation exerts a cardioprotective effect in myocytes by a possible anti-apoptotic mechanism. , 2000, Journal of molecular and cellular cardiology.
[30] P. Pagel,et al. Diabetes abolishes ischemic preconditioning: role of glucose, insulin, and osmolality. , 2000, American journal of physiology. Heart and circulatory physiology.
[31] P. Pagel,et al. Acute hyperglycemia abolishes ischemic preconditioning in vivo. , 1998, The American journal of physiology.
[32] D. Sodi-Pallares,et al. Effects of an intravenous infusion of a potassium-glucose-insulin solution on the electrocardiographic signs of myocardial infarction. A preliminary clinical report. , 1962, The American journal of cardiology.